You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Arabinosine Hydrochloride

Showing 1 - 25 of 1,806
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in Houston (Cyclophosphamide, Vincristine, Blinatumomab)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Dec 23, 2022

Leukemia Trial in Houston (Cladribine, Cytarabine, Decitabine)

Recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 23, 2022

MDS, Myeloproliferative Chronic Myelomonocytic Leukemia Trial in Houston (Cladribine, Cytarabine, Venetoclax)

Recruiting
  • Myelodysplastic Syndromes
  • Myeloproliferative Chronic Myelomonocytic Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Allogeneic Stem Cell Transplant Recipient, Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Recurrent Acute Myeloid

Recruiting
  • Allogeneic Stem Cell Transplant Recipient
  • +3 more
  • Cytarabine Hydrochloride
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Feb 7, 2022

Lymphoma Trial in Houston (AMG 531, Rituximab, Cyclophosphamide)

Completed
Has Results
  • Lymphoma
  • AMG 531
  • +8 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Aug 25, 2021

Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (Nivolumab, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 9, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia Trial in Houston (Clofarabine 40mg/m^2, Idarubicin

Completed
Has Results
  • Acute Myeloid Leukemia
  • +2 more
  • Clofarabine 40mg/m^2
  • +5 more
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 3, 2020

Lymphoma Trial in Houston (Cyclophosphamide, Mesna, Vincristine)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 2, 2020

Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)

Completed
Has Results
  • Lymphoma
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Lymphoma, B-cell Lymphoma Trial in Houston (Leukapheresis, Stem Cell Transplant, CD19-specific T Cell Infusion)

Completed
  • Lymphoma
  • B-cell Lymphoma
  • Leukapheresis
  • +7 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Lymphoma Trial in Houston (Rituximab, Cyclophosphamide, Doxorubicin)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 18, 2020

Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 17, 2020

Leukemia Trial in Houston (LY2510924, Idarubicin, Cytarabine)

Completed
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 14, 2019

Leukemia Trial in Houston (Decitabine, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 28, 2019

Leukemia Trial in Houston (drug, radiation, biological)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 22, 2019

Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Everolimus (RAD001), Cyclophosphamide, Vincristine)

Completed
Has Results
  • Leukemia
  • Acute Lymphocytic Leukemia
  • Everolimus (RAD001)
  • +9 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2019

Acute Myeloid Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 10, 2018

Lymphoma Trial in Houston (biological, drug, procedure, radiation)

Completed
  • Lymphoma
  • Bleomycin Sulfate (BLM)
  • +17 more
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Nov 13, 2018

Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)

Recruiting
  • Diabetic Peripheral Neuropathic Pain
  • HSK16149 20mg BID
  • Luoyang, Henan, China
    The First Affiliated Hospital of Henan University of Science and
Nov 2, 2023

Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)

Not yet recruiting
  • Laparoscopy
  • Anesthesia, Intravenous
  • Guangzhou, Guangdong, China
  • +11 more
Oct 15, 2023

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Pain, Insomnia Trial in Guangzhou (Compound ibuprofen polyrelease tablets, reference 1 (R1): Ibuprofen Tablets (Motrin

Not yet recruiting
  • Pain
  • Insomnia
  • Compound ibuprofen polyrelease tablets
  • reference 1 (R1): Ibuprofen Tablets (Motrin IB®)reference 2 (R2): Diphenhydramine Hydrochloride Tablets (Benadryl®)
  • Guangzhou, Guangdong, China
    Zhujiang Hospital of Southern Medical University
Feb 6, 2023

Breast Cancer Trial in Beijing (Mitoxantrone HCl liposome, Capecitabine)

Not yet recruiting
  • Breast Cancer
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Dec 1, 2023

Non Small Cell Lung Cancer, Propranolol Trial (Propranolol HCl, Sintilimab, Chemotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • Propranolol
  • Propranolol hydrochloride
  • +2 more
  • (no location specified)
Jul 31, 2023

Platinum-resistant Ovarian Cancer Trial in Shanghai (Oral Topotecan Combined With Anlotinib)

Not yet recruiting
  • Platinum-resistant Ovarian Cancer
  • Oral Topotecan Combined With Anlotinib
  • Shanghai, China
    Xinhua Hospital Affiliated to Shanghai Jiaotong University Schoo
Feb 12, 2023